| Literature DB >> 30601144 |
Marcela C Smid1,2,3, Torri D Metz1, Adam J Gordon2,3.
Abstract
Stimulant use, including cocaine, methamphetamines, ecstasy, and prescription stimulants, in pregnancy is increasingly common. In the United States, stimulants are the second most widely used and abused substances during pregnancy and pregnant women using stimulants in pregnancy are at increased risk of adverse perinatal, neonatal, and childhood outcomes. In this review, we describe the pharmacology, pathophysiology, and epidemiology of stimulants, summarize the maternal and neonatal effects of perinatal stimulant use, and outline treatment options for stimulant use disorders among pregnant women. Development of effective treatment strategies for stimulant use disorders identified among pregnant women are urgently needed.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30601144 PMCID: PMC6438363 DOI: 10.1097/GRF.0000000000000418
Source DB: PubMed Journal: Clin Obstet Gynecol ISSN: 0009-9201 Impact factor: 2.190